ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
FibroBiologics Inc

FibroBiologics Inc (FBLG)

4.74
-0.11
(-2.27%)
Closed July 13 4:00PM
4.67
-0.07
(-1.48%)
After Hours: 5:28PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.67
Bid
4.67
Ask
5.03
Volume
85,925
4.69 Day's Range 4.99
3.90 52 Week Range 55.00
Market Cap
Previous Close
4.85
Open
4.85
Last Trade Time
Financial Volume
$ 410,914
VWAP
4.7822
Average Volume (3m)
189,164
Shares Outstanding
32,719,125
Dividend Yield
-
PE Ratio
-8.12
Earnings Per Share (EPS)
-0.58
Revenue
-
Net Profit
-19.06M

About FibroBiologics Inc

FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
FibroBiologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBLG. The last closing price for FibroBiologics was $4.85. Over the last year, FibroBiologics shares have traded in a share price range of $ 3.90 to $ 55.00.

FibroBiologics currently has 32,719,125 shares outstanding. The market capitalization of FibroBiologics is $158.69 million. FibroBiologics has a price to earnings ratio (PE ratio) of -8.12.

FBLG Latest News

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on...

FibroBiologics Set to Join Russell 2000® Index

HOUSTON, June 13, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on...

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on...

FibroBiologics Announces 2024 Annual Meeting of Stockholders

HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...

FibroBiologics Files 2024 First Quarter Report

HOUSTON, May 14, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending for the development...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.4711.19047619054.25.494.22294564.92015552CS
4-2.93-38.55263157897.67.773.92500304.90502767CS
12-6.44-57.965796579711.1113.593.91891647.87219662CS
26-25.33-84.433333333330553.91464779.52207533CS
52-25.33-84.433333333330553.91464779.52207533CS
156-25.33-84.433333333330553.91464779.52207533CS
260-25.33-84.433333333330553.91464779.52207533CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Your Recent History

Delayed Upgrade Clock